Presence of abdominal aortic calcification is significantly associated with all-cause and cardiovascular mortality in maintenance hemodialysis

被引:223
作者
Okuno, Senji
Ishimura, Eiji
Kitatani, Kayoko
Fujino, Yoko
Kohno, Kaori
Maeno, Yoshifumi
Maekawa, Kiyoshi
Yamakawa, Tomoyuki
Imanishi, Yasuo
Inaba, Masaaki
Nishizawa, Yoshiki
机构
[1] Osaka City Univ, Grad Sch Med, Dept Nephrol, Abeno Ku, Osaka 5458585, Japan
[2] Osaka City Univ, Grad Sch Med, Dept Metab Endocrinol & Mol Med, Osaka 558, Japan
[3] Shirasagi Hosp, Kidney Ctr, Osaka, Japan
关键词
abdominal aorta; calcification; all-cause mortality; cardiovascular mortality; hemodialysis;
D O I
10.1053/j.ajkd.2006.12.017
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Although abdominal aortic calcification (AAC) is reported as a predictor for cardiovascular mortality in the general population, it is unknown whether this is also true in hemodialysis patients in whom vascular calcification and cardiovascular diseases are highly prevalent. Study Design: Cohort study. Settings & Participants: 515 patients on maintenance hemodialysis therapy at a single center. Predictor: AAC evaluated in a plain roentgenograph of the lateral abdomen at baseline. Outcomes & Measurements: All-cause and cardiovascular death. Results: Mean age was 60 +/- 12 (SD) years. AAC was present in 291 patients (56.5%). During a mean follow-up period of 51 +/- 17 months, there were 103 all-cause deaths, of which 41 were from cardiovascular diseases. Of patients with and without AAC, 27.8% and 9.8% died, respectively (11.6% and 3.1% of cardiovascular diseases, respectively). Kaplan-Meier analysis showed that all-cause mortality was significantly greater inpatients with AAC compared to those without (P < 0.0001, log-rank test). Similarly, cardiovascular mortality was significantly greater in the former than in the latter group (P = 0.0001, log-rank test). Multivariate Cox proportional hazards analysis found that the presence of AAC was significantly associated with increased all-cause mortality (hazard ratio, 2.07; 95% confidence interval, 1.21 to 3.56; P < 0.01) and increased cardiovascular mortality (hazard ratio, 2.39; 95% confidence interval, 1.01 to 5.66; P < 0.05) after adjustment for age, hemodialysis duration, presence of diabetes, serum albumin level, and C-reactive protein level. Limitations: Nonquantitative assessment of AAC and the lack of information for medication and history of cardiovascular diseases. Conclusion: The presence of AAC is significantly associated with both all-cause and cardiovascular mortality in hemodialysis patients, suggesting that careful attention should be given to the presence of AAC in a simple radiograph of the lateral abdomen as a prognostic indicator.
引用
收藏
页码:417 / 425
页数:9
相关论文
共 28 条
[11]   Large artery stiffness predicts ischemic threshold in patients with coronary artery disease [J].
Kingwell, BA ;
Waddell, TK ;
Medley, TL ;
Cameron, JD ;
Dart, AM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (04) :773-779
[12]   Arterial wall stiffness is associated with peripheral circulation in patients with type 2 diabetes [J].
Kizu, A ;
Koyama, H ;
Tanaka, S ;
Maeno, T ;
Komatsu, M ;
Fukumoto, S ;
Emoto, M ;
Shoji, T ;
Inaba, M ;
Shioi, A ;
Miki, T ;
Nishizawa, Y .
ATHEROSCLEROSIS, 2003, 170 (01) :87-91
[13]   Cardiovascular calcifications in uremic patients: Clinical impact on cardiovascular function [J].
London, GM .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (09) :S305-S309
[14]   Arterial media calcification in end-stage renal disease:: impact on all-cause and cardiovascular mortality [J].
London, GM ;
Guérin, AP ;
Marchais, SJ ;
Métivier, F ;
Pannier, B ;
Adda, H .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (09) :1731-1740
[15]   HMG-coenzyme A reductase inhibitor use is associated with mortality reduction in hemodialysis patients [J].
Mason, NA ;
Bailie, GR ;
Satayathum, S ;
Bragg-Gresham, JL ;
Akiba, T ;
Akizawa, T ;
Combe, C ;
Rayner, HC ;
Saito, A ;
Gillespie, BW ;
Young, EW .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (01) :119-126
[16]   Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis [J].
Matsuoka M. ;
Iseki K. ;
Tamashiro M. ;
Fujimoto N. ;
Higa N. ;
Touma T. ;
Takishita S. .
Journal of Clinical and Experimental Nephrology, 2004, 8 (1) :54-58
[17]   The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis [J].
Nitta, K ;
Akiba, T ;
Uchida, K ;
Kawashima, A ;
Yumura, W ;
Kabaya, T ;
Nihei, H .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (02) :303-309
[18]   Cardiac calcification in adult Hemodialysis patients - A link between end-stage renal disease and cardiovascular disease? [J].
Raggi, P ;
Boulay, A ;
Chasan-Taber, S ;
Amin, N ;
Dillon, M ;
Burke, SK ;
Chertow, GM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (04) :695-701
[19]   Comparison of coronary calcium in stable angina pectoris and in first acute myocardial infarction utilizing double helical computerized tomography [J].
Shemesh, J ;
Stroh, CI ;
Tenenbaum, A ;
Hod, H ;
Boyko, V ;
Fisman, EZ ;
Motro, M .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (03) :271-275
[20]   Lower risk for cardiovascular mortality in oral 1α-hydroxy vitamin D3 users in a haemodialysis population [J].
Shoji, T ;
Shinohara, K ;
Kimoto, E ;
Emoto, M ;
Tahara, H ;
Koyama, H ;
Inaba, M ;
Fukumoto, S ;
Ishimura, E ;
Miki, T ;
Tabata, T ;
Nishizawa, Y .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (01) :179-184